CA
NZ
UK
AU
IND
US
…
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
INVO Fertility, Inc. develops and sells reproductive-health products and services, notably the INVOcell intravaginal embryo incubation device, together with clinic support and device sales. Long-term growth may be driven by rising demand for assisted reproduction, adoption of lower-cost IVF alternatives, and expansion of clinic and licensing relationships, which could attract investors seeking fertility-technology exposure.
Principal risks include limited scale and historical losses, reliance on regulatory clearance and physician adoption, intense competition from established providers, and possible capital constraints.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -5.49M | -9.12M | -8.01M | -10.89M | -6.65M |
| Net income | -23.32M | -9.10M | -8.03M | -10.89M | -6.65M |
| Selling general administrative | 7.69M | 9.08M | 7.49M | 9.98M | 9.02M |
| Gross profit | 2.53M | 2.87M | 1.09M | -0.03M | 4.02M |
| Reconciled depreciation | 0.68M | 0.92M | 0.20M | 0.08M | 0.17M |
| Ebit | -4.18M | -8.06M | -7.08M | -10.83M | -5.38M |
| Ebitda | -3.51M | -7.14M | -6.88M | -10.75M | -5.22M |
| Depreciation and amortization | 0.68M | 0.92M | 0.20M | 0.08M | 0.17M |
| Operating income | -5.84M | -8.13M | -6.77M | -10.63M | -5.22M |
| Other operating expenses | 12.68M | 14.66M | 9.79M | 11.45M | 9.38M |
| Interest expense | 1.30M | 1.06M | 0.93M | 0.06M | 1.27M |
| Tax provision | -0.15M | -0.02M | 0.03M | 0.00M | 0.00M |
| Interest income | - | - | 0.00M | 0.00M | 0.00M |
| Net interest income | -1.30M | -1.06M | -0.93M | -0.06M | -1.26M |
| Income tax expense | -0.15M | -0.02M | 0.03M | 0.00M | 0.00M |
| Total revenue | 6.84M | 6.53M | 3.02M | 0.82M | 4.16M |
| Total operating expenses | 8.37M | 11.00M | 7.85M | 10.60M | 9.23M |
| Cost of revenue | 4.31M | 3.66M | 1.93M | 0.85M | 0.15M |
| Total other income expense net | 0.35M | -0.99M | -1.24M | -0.26M | -1.43M |
| Net income from continuing ops | -5.34M | -9.10M | -8.03M | -10.89M | -6.65M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 20.22M | 46.45M | 18.51M | 3.71M | 10.47M |
| Intangible assets | 1.33M | 18.10M | 4.09M | - | 0.13M |
| Other current assets | 0.24M | 0.18M | 0.62M | 0.19M | 0.28M |
| Total liab | 13.00M | 33.70M | 17.61M | 4.69M | 3.16M |
| Total stockholder equity | 7.22M | 12.75M | 0.89M | -0.98M | 7.31M |
| Other current liab | 6.09M | 5.03M | 3.57M | 0.95M | 0.58M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 2.41M | 30.38M | 6.00M | 0.00M | 0.00M |
| Retained earnings | -91.37M | -67.16M | -57.82M | -49.78M | -38.89M |
| Good will | 5.88M | 23.54M | 5.88M | 0.00M | - |
| Cash | 2.08M | 0.74M | 0.23M | 0.09M | 5.68M |
| Total current liabilities | 10.33M | 17.93M | 8.00M | 3.34M | 1.25M |
| Current deferred revenue | 0.72M | 0.60M | 0.41M | 0.12M | 0.01M |
| Net debt | 1.32M | 9.15M | 6.07M | 2.18M | -3.56M |
| Short term debt | 1.48M | 6.58M | 1.69M | 0.92M | 0.22M |
| Short long term debt | 1.27M | 6.34M | 1.51M | 0.76M | - |
| Short long term debt total | 3.40M | 9.90M | 6.30M | 2.27M | 2.12M |
| Other stockholder equity | 96.19M | 49.54M | 52.71M | 48.81M | 46.20M |
| Total current assets | 2.76M | 1.32M | 1.26M | 0.62M | 6.31M |
| Long term investments | 2.47M | 0.74M | 3.09M | 1.24M | 1.49M |
| Net receivables | 0.22M | 0.17M | 0.14M | 0.08M | 0.05M |
| Long term debt | 0.74M | 1.13M | 1.25M | - | - |
| Inventory | 0.23M | 0.22M | 0.26M | 0.26M | 0.29M |
| Accounts payable | 2.03M | 5.71M | 2.33M | 1.35M | 0.44M |
| Non currrent assets other | 6.12M | 32.48M | - | - | - |
| Non current assets total | 17.46M | 45.13M | 17.25M | 3.09M | 4.16M |
| Capital lease obligations | 1.38M | 2.43M | 3.54M | 1.51M | 2.12M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 0.36M | -2.49M | -0.08M | -2.15M |
| Total cashflows from investing activities | -2.75M | 0.36M | -2.49M | -0.08M | -2.15M |
| Net borrowings | -1.22M | 0.41M | 1.66M | 0.80M | -0.25M |
| Total cash from financing activities | 11.10M | 3.12M | 7.39M | 1.09M | 3.77M |
| Net income | -23.32M | -9.10M | -8.03M | -10.89M | -6.65M |
| Change in cash | 1.34M | 0.51M | 0.14M | -5.59M | -4.41M |
| Begin period cash flow | 0.74M | 0.23M | 0.09M | 5.68M | 10.10M |
| End period cash flow | 2.08M | 0.74M | 0.23M | 0.09M | 5.68M |
| Total cash from operating activities | -7.01M | -2.97M | -4.76M | -6.60M | -6.03M |
| Issuance of capital stock | 15.21M | 1.81M | 5.70M | 0.29M | 3.65M |
| Depreciation | 0.68M | 0.92M | 0.20M | 0.08M | 0.17M |
| Other cashflows from investing activities | - | 0.08M | - | -0.00M | -0.04M |
| Change to inventory | -0.01M | 0.04M | -0.00M | 0.02M | -0.02M |
| Change to account receivables | -0.10M | -0.03M | -0.06M | -0.03M | -0.03M |
| Sale purchase of stock | -4.00M | 0.00M | - | - | - |
| Other cashflows from financing activities | 2.85M | 2.54M | 0.03M | - | 0.37M |
| Capital expenditures | 0.04M | 0.18M | 0.44M | 0.01M | 0.45M |
| Change in working capital | -1.68M | 1.86M | 0.47M | 1.48M | -3.61M |
| Stock based compensation | 1.47M | 1.59M | 1.39M | 2.22M | 2.71M |
| Other non cash items | 15.84M | 1.75M | 2.61M | 0.51M | 1.36M |
| Free cash flow | -7.06M | -3.16M | -5.20M | -6.62M | -6.48M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| IVF INVO Fertility, Inc. |
-0.06 9.74% |
0.56 | - | - | 0.32 | 0.15 | 0.40 | -1.24 |
| ABT Abbott Laboratories |
-0.46 0.45% |
102.64 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
0.83 0.88% |
94.78 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
2.58 0.86% |
304.00 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
- -% |
47.39 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
5582 Broadcast Court, Sarasota, FL, United States, 34240
978 878 9505
40
| Name | Title | Year Born |
|---|---|---|
| Mr. Steven M. Shum | CEO & Director | 1971 |
| Ms. Terah Krigsvold | Chief Financial Officer | 1983 |
| Mr. Andrea Goren | Chief Business Officer | 1967 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.02%
Communication Services
-0.63%
Consumer Cyclical
-0.11%
Consumer Defensive
-0.45%
Energy
+0.39%
Financial Services
-0.10%
Financials
-0.81%
Healthcare
+1.03%
Industrials
+0.32%
Real Estate
-0.31%
Technology
+0.59%
Utilities
-0.18%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...